-
Natalia
Frias-Staheli,
N.
Giannakopoulos,
M.
Kikkert,
Shannon
Taylor,
A.
Bridgen,
J.
Paragas,
J.
Richt,
R.
Rowland,
C.
Schmaljohn,
D.
Lenschow,
E.
Snijder,
A.
García-Sastre,
H.
Virgin
(2007)
Ovarian Tumor Domain-Containing Viral Proteases Evade Ubiquitin- and ISG15-Dependent Innate Immune Responses
Cell Host & Microbe, 2
-
(Watanabe
SM, Ehrlich
LS, Strickland
M, Li
X, Soloveva
V, Goff
AJ, Stauft
CB, Bhaduri-McIntosh
S, Tjandra
N, Carter
C. 2020. Selective targeting of virus replication by proton pump inhibitors. Sci Rep
10:4003. 10.1038/s41598-020-60544-y.32132561)
Watanabe
SM, Ehrlich
LS, Strickland
M, Li
X, Soloveva
V, Goff
AJ, Stauft
CB, Bhaduri-McIntosh
S, Tjandra
N, Carter
C. 2020. Selective targeting of virus replication by proton pump inhibitors. Sci Rep
10:4003. 10.1038/s41598-020-60544-y.32132561
Watanabe
SM, Ehrlich
LS, Strickland
M, Li
X, Soloveva
V, Goff
AJ, Stauft
CB, Bhaduri-McIntosh
S, Tjandra
N, Carter
C. 2020. Selective targeting of virus replication by proton pump inhibitors. Sci Rep
10:4003. 10.1038/s41598-020-60544-y.32132561, Watanabe
SM, Ehrlich
LS, Strickland
M, Li
X, Soloveva
V, Goff
AJ, Stauft
CB, Bhaduri-McIntosh
S, Tjandra
N, Carter
C. 2020. Selective targeting of virus replication by proton pump inhibitors. Sci Rep
10:4003. 10.1038/s41598-020-60544-y.32132561
-
Lynn
Verplank,
F.
Bouamr,
Tracy
LaGrassa,
B.
Agresta,
A.
Kikonyogo,
J.
Leis,
C.
Carter
(2001)
Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag
Proceedings of the National Academy of Sciences of the United States of America, 98
-
(Corless
L, Crump
CM, Griffin
SD, Harris
M. 2010. Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles. J Gen Virol
91:362–372. 10.1099/vir.0.017285-0.19828764)
Corless
L, Crump
CM, Griffin
SD, Harris
M. 2010. Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles. J Gen Virol
91:362–372. 10.1099/vir.0.017285-0.19828764
Corless
L, Crump
CM, Griffin
SD, Harris
M. 2010. Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles. J Gen Virol
91:362–372. 10.1099/vir.0.017285-0.19828764, Corless
L, Crump
CM, Griffin
SD, Harris
M. 2010. Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles. J Gen Virol
91:362–372. 10.1099/vir.0.017285-0.19828764
-
(Lu
J, Han
Z, Liu
Y, Liu
W, Lee
MS, Olson
MA, Ruthel
G, Freedman
BD, Harty
RN. 2014. A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress. J Virol
88:4736–4743. 10.1128/JVI.03757-13.24522922)
Lu
J, Han
Z, Liu
Y, Liu
W, Lee
MS, Olson
MA, Ruthel
G, Freedman
BD, Harty
RN. 2014. A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress. J Virol
88:4736–4743. 10.1128/JVI.03757-13.24522922
Lu
J, Han
Z, Liu
Y, Liu
W, Lee
MS, Olson
MA, Ruthel
G, Freedman
BD, Harty
RN. 2014. A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress. J Virol
88:4736–4743. 10.1128/JVI.03757-13.24522922, Lu
J, Han
Z, Liu
Y, Liu
W, Lee
MS, Olson
MA, Ruthel
G, Freedman
BD, Harty
RN. 2014. A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress. J Virol
88:4736–4743. 10.1128/JVI.03757-13.24522922
-
J.
Arii,
Mizuki
Watanabe,
Fumio
Maeda,
N.
Tokai‐Nishizumi,
T.
Chihara,
M.
Miura,
Yuhei
Maruzuru,
Naoto
Koyanagi,
Akihisa
Kato,
Y.
Kawaguchi
(2018)
ESCRT-III mediates budding across the inner nuclear membrane and regulates its integrity
Nature Communications, 9
-
U.
Schwedler,
M.
Stuchell,
B.
Müller,
D.
Ward,
Hyo‐Young
Chung,
E.
Morita,
Hubert
Wang,
Thaylon
Davis,
G.
He,
D.
Cimbora,
Anna
Scott,
H.
Kräusslich,
J.
Kaplan,
S.
Morham,
W.
Sundquist
(2003)
The Protein Network of HIV Budding
Cell, 114
-
Tobias
Pawliczek,
C.
Crump
(2009)
Herpes Simplex Virus Type 1 Production Requires a Functional ESCRT-III Complex but Is Independent of TSG101 and ALIX Expression
Journal of Virology, 83
-
(Urata
S, Noda
T, Kawaoka
Y, Morikawa
S, Yokosawa
H, Yasuda
J. 2007. Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP. J Virol
81:4895–4899. 10.1128/JVI.02829-06.17301151)
Urata
S, Noda
T, Kawaoka
Y, Morikawa
S, Yokosawa
H, Yasuda
J. 2007. Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP. J Virol
81:4895–4899. 10.1128/JVI.02829-06.17301151
Urata
S, Noda
T, Kawaoka
Y, Morikawa
S, Yokosawa
H, Yasuda
J. 2007. Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP. J Virol
81:4895–4899. 10.1128/JVI.02829-06.17301151, Urata
S, Noda
T, Kawaoka
Y, Morikawa
S, Yokosawa
H, Yasuda
J. 2007. Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP. J Virol
81:4895–4899. 10.1128/JVI.02829-06.17301151
-
A.
Schmitt,
G.
Leser,
David
Waning,
R.
Lamb
(2002)
Requirements for Budding of Paramyxovirus Simian Virus 5 Virus-Like Particles
Journal of Virology, 76
-
(Kuang
Z, Seo
EJ, Leis
J. 2011. Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15. J Virol
85:7153–7161. 10.1128/JVI.02610-10.21543490)
Kuang
Z, Seo
EJ, Leis
J. 2011. Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15. J Virol
85:7153–7161. 10.1128/JVI.02610-10.21543490
Kuang
Z, Seo
EJ, Leis
J. 2011. Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15. J Virol
85:7153–7161. 10.1128/JVI.02610-10.21543490, Kuang
Z, Seo
EJ, Leis
J. 2011. Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15. J Virol
85:7153–7161. 10.1128/JVI.02610-10.21543490
-
G.
Medina,
Andrew
Pincetic,
L.
Ehrlich,
Yongjun
Zhang,
Yi
Tang,
J.
Leis,
C.
Carter
(2008)
Tsg101 can replace Nedd4 function in ASV Gag release but not membrane targeting.
Virology, 377 1
-
(Han
Z, Lu
J, Liu
Y, Davis
B, Lee
MS, Olson
MA, Ruthel
G, Freedman
BD, Schnell
MJ, Wrobel
JE, Reitz
AB, Harty
RN. 2014. Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses. J Virol
88:7294–7306. 10.1128/JVI.00591-14.24741084)
Han
Z, Lu
J, Liu
Y, Davis
B, Lee
MS, Olson
MA, Ruthel
G, Freedman
BD, Schnell
MJ, Wrobel
JE, Reitz
AB, Harty
RN. 2014. Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses. J Virol
88:7294–7306. 10.1128/JVI.00591-14.24741084
Han
Z, Lu
J, Liu
Y, Davis
B, Lee
MS, Olson
MA, Ruthel
G, Freedman
BD, Schnell
MJ, Wrobel
JE, Reitz
AB, Harty
RN. 2014. Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses. J Virol
88:7294–7306. 10.1128/JVI.00591-14.24741084, Han
Z, Lu
J, Liu
Y, Davis
B, Lee
MS, Olson
MA, Ruthel
G, Freedman
BD, Schnell
MJ, Wrobel
JE, Reitz
AB, Harty
RN. 2014. Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses. J Virol
88:7294–7306. 10.1128/JVI.00591-14.24741084
-
J.
Wills,
Craig
Cameron,
Craig
Cameron,
C.
Wilson,
Yan
Xiang,
R.
Bennett,
Jonathan
Leis
(1994)
An assembly domain of the Rous sarcoma virus Gag protein required late in budding
Journal of Virology, 68
-
H.
Göttlinger,
T.
Dorfman,
J.
Sodroski,
W.
Haseltine
(1991)
Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.
Proceedings of the National Academy of Sciences of the United States of America, 88
-
(Garrus
JE, von Schwedler
UK, Pornillos
OW, Morham
SG, Zavitz
KH, Wang
HE, Wettstein
DA, Stray
KM, Cote
M, Rich
RL, Myszka
DG, Sundquist
WI. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell
107:55–65. 10.1016/s0092-8674(01)00506-2.11595185)
Garrus
JE, von Schwedler
UK, Pornillos
OW, Morham
SG, Zavitz
KH, Wang
HE, Wettstein
DA, Stray
KM, Cote
M, Rich
RL, Myszka
DG, Sundquist
WI. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell
107:55–65. 10.1016/s0092-8674(01)00506-2.11595185
Garrus
JE, von Schwedler
UK, Pornillos
OW, Morham
SG, Zavitz
KH, Wang
HE, Wettstein
DA, Stray
KM, Cote
M, Rich
RL, Myszka
DG, Sundquist
WI. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell
107:55–65. 10.1016/s0092-8674(01)00506-2.11595185, Garrus
JE, von Schwedler
UK, Pornillos
OW, Morham
SG, Zavitz
KH, Wang
HE, Wettstein
DA, Stray
KM, Cote
M, Rich
RL, Myszka
DG, Sundquist
WI. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell
107:55–65. 10.1016/s0092-8674(01)00506-2.11595185
-
(Silvestri
LS, Ruthel
G, Kallstrom
G, Warfield
KL, Swenson
DL, Nelle
T, Iversen
PL, Bavari
S, Aman
MJ. 2007. Involvement of vacuolar protein sorting pathway in Ebola virus release independent of TSG101 interaction. J Infect Dis
196(Suppl 2):S264–S270. 10.1086/520610.17940959)
Silvestri
LS, Ruthel
G, Kallstrom
G, Warfield
KL, Swenson
DL, Nelle
T, Iversen
PL, Bavari
S, Aman
MJ. 2007. Involvement of vacuolar protein sorting pathway in Ebola virus release independent of TSG101 interaction. J Infect Dis
196(Suppl 2):S264–S270. 10.1086/520610.17940959
Silvestri
LS, Ruthel
G, Kallstrom
G, Warfield
KL, Swenson
DL, Nelle
T, Iversen
PL, Bavari
S, Aman
MJ. 2007. Involvement of vacuolar protein sorting pathway in Ebola virus release independent of TSG101 interaction. J Infect Dis
196(Suppl 2):S264–S270. 10.1086/520610.17940959, Silvestri
LS, Ruthel
G, Kallstrom
G, Warfield
KL, Swenson
DL, Nelle
T, Iversen
PL, Bavari
S, Aman
MJ. 2007. Involvement of vacuolar protein sorting pathway in Ebola virus release independent of TSG101 interaction. J Infect Dis
196(Suppl 2):S264–S270. 10.1086/520610.17940959
-
(Luan
C-H, Light
SH, Dunne
SF, Anderson
WF. 2014. Ligand screening using fluorescence thermal shift analysis (FTS). Methods Mol Biol
1140:263–289. 10.1007/978-1-4939-0354-2_20.24590724)
Luan
C-H, Light
SH, Dunne
SF, Anderson
WF. 2014. Ligand screening using fluorescence thermal shift analysis (FTS). Methods Mol Biol
1140:263–289. 10.1007/978-1-4939-0354-2_20.24590724
Luan
C-H, Light
SH, Dunne
SF, Anderson
WF. 2014. Ligand screening using fluorescence thermal shift analysis (FTS). Methods Mol Biol
1140:263–289. 10.1007/978-1-4939-0354-2_20.24590724, Luan
C-H, Light
SH, Dunne
SF, Anderson
WF. 2014. Ligand screening using fluorescence thermal shift analysis (FTS). Methods Mol Biol
1140:263–289. 10.1007/978-1-4939-0354-2_20.24590724
-
J.
Garrus,
U.
Schwedler,
O.
Pornillos,
S.
Morham,
K.
Zavitz,
Hubert
Wang,
D.
Wettstein,
Kirsten
Stray,
M.
Côté,
R.
Rich,
D.
Myszka,
W.
Sundquist
(2001)
Tsg101 and the Vacuolar Protein Sorting Pathway Are Essential for HIV-1 Budding
Cell, 107
-
Mar
Perez,
R.
Craven,
J.
Torre
(2003)
The small RING finger protein Z drives arenavirus budding: Implications for antiviral strategies
Proceedings of the National Academy of Sciences of the United States of America, 100
-
(Kakinoki
B, Ono
C, Yamazaki
N, Chikamatsu
N, Wakatsuki
D, Uchiyama
K, Morinaka
Y. 1999. General pharmacological properties of the new proton pump inhibitor (+/−)-5-methoxy-2-(((4-methoxy-3,5-dimethylpyrid-2-yl)methyl)sulfinyl)-1H-imidazo(4,5-b)pryidine. Methods Find Exp Clin Pharmacol
21:179–187. 10.1358/mf.1999.21.3.534827.10389120)
Kakinoki
B, Ono
C, Yamazaki
N, Chikamatsu
N, Wakatsuki
D, Uchiyama
K, Morinaka
Y. 1999. General pharmacological properties of the new proton pump inhibitor (+/−)-5-methoxy-2-(((4-methoxy-3,5-dimethylpyrid-2-yl)methyl)sulfinyl)-1H-imidazo(4,5-b)pryidine. Methods Find Exp Clin Pharmacol
21:179–187. 10.1358/mf.1999.21.3.534827.10389120
Kakinoki
B, Ono
C, Yamazaki
N, Chikamatsu
N, Wakatsuki
D, Uchiyama
K, Morinaka
Y. 1999. General pharmacological properties of the new proton pump inhibitor (+/−)-5-methoxy-2-(((4-methoxy-3,5-dimethylpyrid-2-yl)methyl)sulfinyl)-1H-imidazo(4,5-b)pryidine. Methods Find Exp Clin Pharmacol
21:179–187. 10.1358/mf.1999.21.3.534827.10389120, Kakinoki
B, Ono
C, Yamazaki
N, Chikamatsu
N, Wakatsuki
D, Uchiyama
K, Morinaka
Y. 1999. General pharmacological properties of the new proton pump inhibitor (+/−)-5-methoxy-2-(((4-methoxy-3,5-dimethylpyrid-2-yl)methyl)sulfinyl)-1H-imidazo(4,5-b)pryidine. Methods Find Exp Clin Pharmacol
21:179–187. 10.1358/mf.1999.21.3.534827.10389120
-
Andrew
Pincetic,
J.
Leis
(2009)
The Mechanism of Budding of Retroviruses from Cell Membranes
Advances in Virology, 2009
-
Jonathan
Madara,
Ziying
Han,
G.
Ruthel,
B.
Freedman,
R.
Harty
(2015)
The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target.
Future virology, 10 5
-
T.
Irie,
R.
Harty
(2005)
L-Domain Flanking Sequences Are Important for Host Interactions and Efficient Budding of Vesicular Stomatitis Virus Recombinants
Journal of Virology, 79
-
(Frias-Staheli
N, Giannakopoulos
NV, Kikkert
M, Taylor
SL, Bridgen
A, Paragas
J, Richt
JA, Rowland
RR, Schmaljohn
CS, Lenschow
DJ, Snijder
EJ, García-Sastre
A, Virgin
HW, IV.
2007. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe
2:404–416. 10.1016/j.chom.2007.09.014.18078692)
Frias-Staheli
N, Giannakopoulos
NV, Kikkert
M, Taylor
SL, Bridgen
A, Paragas
J, Richt
JA, Rowland
RR, Schmaljohn
CS, Lenschow
DJ, Snijder
EJ, García-Sastre
A, Virgin
HW, IV.
2007. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe
2:404–416. 10.1016/j.chom.2007.09.014.18078692
Frias-Staheli
N, Giannakopoulos
NV, Kikkert
M, Taylor
SL, Bridgen
A, Paragas
J, Richt
JA, Rowland
RR, Schmaljohn
CS, Lenschow
DJ, Snijder
EJ, García-Sastre
A, Virgin
HW, IV.
2007. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe
2:404–416. 10.1016/j.chom.2007.09.014.18078692, Frias-Staheli
N, Giannakopoulos
NV, Kikkert
M, Taylor
SL, Bridgen
A, Paragas
J, Richt
JA, Rowland
RR, Schmaljohn
CS, Lenschow
DJ, Snijder
EJ, García-Sastre
A, Virgin
HW, IV.
2007. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe
2:404–416. 10.1016/j.chom.2007.09.014.18078692
-
(Goff
A, Ehrlich
LS, Cohen
SN, Carter
CA. 2003. Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release. J Virol
77:9173–9182. 10.1128/jvi.77.17.9173-9182.2003.12915533)
Goff
A, Ehrlich
LS, Cohen
SN, Carter
CA. 2003. Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release. J Virol
77:9173–9182. 10.1128/jvi.77.17.9173-9182.2003.12915533
Goff
A, Ehrlich
LS, Cohen
SN, Carter
CA. 2003. Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release. J Virol
77:9173–9182. 10.1128/jvi.77.17.9173-9182.2003.12915533, Goff
A, Ehrlich
LS, Cohen
SN, Carter
CA. 2003. Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release. J Virol
77:9173–9182. 10.1128/jvi.77.17.9173-9182.2003.12915533
-
Jianhong
Lu,
Ziying
Han,
Yuliang
Liu,
Wenbo
Liu,
Michael
Lee,
M.
Olson,
G.
Ruthel,
B.
Freedman,
R.
Harty
(2014)
A Host-Oriented Inhibitor of Junin Argentine Hemorrhagic Fever Virus Egress
Journal of Virology, 88
-
Weiming
Yuan,
R.
Krug
(2001)
Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)‐induced ubiquitin‐like ISG15 protein
The EMBO Journal, 20
-
Ziying
Han,
Jianhong
Lu,
Yuliang
Liu,
Benjamin
Davis,
Michael
Lee,
M.
Olson,
G.
Ruthel,
B.
Freedman,
M.
Schnell,
J.
Wrobel,
A.
Reitz,
R.
Harty
(2014)
Small-Molecule Probes Targeting the Viral PPxY-Host Nedd4 Interface Block Egress of a Broad Range of RNA Viruses
Journal of Virology, 88
-
Ming
Li,
Phuong
Schmitt,
Zhuo
Li,
Thomas
McCrory,
B.
He,
A.
Schmitt
(2009)
Mumps Virus Matrix, Fusion, and Nucleocapsid Proteins Cooperate for Efficient Production of Virus-Like Particles
Journal of Virology, 83
-
Y.
Usami,
S.
Popov,
E.
Popova,
H.
Göttlinger
(2008)
Efficient and Specific Rescue of Human Immunodeficiency Virus Type 1 Budding Defects by a Nedd4-Like Ubiquitin Ligase
Journal of Virology, 82
-
(Timmins
J, Schoehn
G, Ricard-Blum
S, Scianimanico
S, Vernet
T, Ruigrok
RW, Weissenhorn
W. 2003. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J Mol Biol
326:493–502. 10.1016/s0022-2836(02)01406-7.12559917)
Timmins
J, Schoehn
G, Ricard-Blum
S, Scianimanico
S, Vernet
T, Ruigrok
RW, Weissenhorn
W. 2003. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J Mol Biol
326:493–502. 10.1016/s0022-2836(02)01406-7.12559917
Timmins
J, Schoehn
G, Ricard-Blum
S, Scianimanico
S, Vernet
T, Ruigrok
RW, Weissenhorn
W. 2003. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J Mol Biol
326:493–502. 10.1016/s0022-2836(02)01406-7.12559917, Timmins
J, Schoehn
G, Ricard-Blum
S, Scianimanico
S, Vernet
T, Ruigrok
RW, Weissenhorn
W. 2003. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J Mol Biol
326:493–502. 10.1016/s0022-2836(02)01406-7.12559917
-
(Schmitt
AP, Leser
GP, Waning
DL, Lamb
RA. 2002. Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol
76:3952–3964. 10.1128/jvi.76.8.3952-3964.2002.11907235)
Schmitt
AP, Leser
GP, Waning
DL, Lamb
RA. 2002. Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol
76:3952–3964. 10.1128/jvi.76.8.3952-3964.2002.11907235
Schmitt
AP, Leser
GP, Waning
DL, Lamb
RA. 2002. Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol
76:3952–3964. 10.1128/jvi.76.8.3952-3964.2002.11907235, Schmitt
AP, Leser
GP, Waning
DL, Lamb
RA. 2002. Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol
76:3952–3964. 10.1128/jvi.76.8.3952-3964.2002.11907235
-
K.
Fujii,
U.
Munshi,
S.
Ablan,
D.
Demirov,
F.
Soheilian,
K.
Nagashima,
A.
Stephen,
R.
Fisher,
E.
Freed
(2009)
Functional role of Alix in HIV-1 replication.
Virology, 391 2
-
B.
Strack,
A.
Calistri,
S.
Craig,
E.
Popova,
H.
Göttlinger
(2003)
AIP1/ALIX Is a Binding Partner for HIV-1 p6 and EIAV p9 Functioning in Virus Budding
Cell, 114
-
(Pawliczek
T, Crump
CM. 2009. Herpes simplex virus type 1 production requires a functional ESCRT-III complex but is independent of TSG101 and ALIX expression. J Virol
83:11254–11264. 10.1128/JVI.00574-09.19692479)
Pawliczek
T, Crump
CM. 2009. Herpes simplex virus type 1 production requires a functional ESCRT-III complex but is independent of TSG101 and ALIX expression. J Virol
83:11254–11264. 10.1128/JVI.00574-09.19692479
Pawliczek
T, Crump
CM. 2009. Herpes simplex virus type 1 production requires a functional ESCRT-III complex but is independent of TSG101 and ALIX expression. J Virol
83:11254–11264. 10.1128/JVI.00574-09.19692479, Pawliczek
T, Crump
CM. 2009. Herpes simplex virus type 1 production requires a functional ESCRT-III complex but is independent of TSG101 and ALIX expression. J Virol
83:11254–11264. 10.1128/JVI.00574-09.19692479
-
Hyo‐Young
Chung,
E.
Morita,
U.
Schwedler,
B.
Müller,
H.
Kräusslich,
W.
Sundquist
(2008)
NEDD4L Overexpression Rescues the Release and Infectivity of Human Immunodeficiency Virus Type 1 Constructs Lacking PTAP and YPXL Late Domains
Journal of Virology, 82
-
(Wills
JW, Cameron
CE, Wilson
CB, Xiang
Y, Bennett
RP, Leis
J. 1994. An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol
68:6605–6618. 10.1128/JVI.68.10.6605-6618.1994.8083996)
Wills
JW, Cameron
CE, Wilson
CB, Xiang
Y, Bennett
RP, Leis
J. 1994. An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol
68:6605–6618. 10.1128/JVI.68.10.6605-6618.1994.8083996
Wills
JW, Cameron
CE, Wilson
CB, Xiang
Y, Bennett
RP, Leis
J. 1994. An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol
68:6605–6618. 10.1128/JVI.68.10.6605-6618.1994.8083996, Wills
JW, Cameron
CE, Wilson
CB, Xiang
Y, Bennett
RP, Leis
J. 1994. An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol
68:6605–6618. 10.1128/JVI.68.10.6605-6618.1994.8083996
-
D.
Bojkova,
Jake
McGreig,
Katie-May
McLaughlin,
Stuart
Masterson,
M.
Widera,
Verena
Krähling,
S.
Ciesek,
M.
Wass,
M.
Michaelis,
J.
Cinatl
(2020)
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles
bioRxiv
-
(Carlton
JG, Martin-Serrano
J. 2007. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science
316:1908–1912. 10.1126/science.1143422.17556548)
Carlton
JG, Martin-Serrano
J. 2007. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science
316:1908–1912. 10.1126/science.1143422.17556548
Carlton
JG, Martin-Serrano
J. 2007. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science
316:1908–1912. 10.1126/science.1143422.17556548, Carlton
JG, Martin-Serrano
J. 2007. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science
316:1908–1912. 10.1126/science.1143422.17556548
-
(Vana
ML, Tang
Y, Chen
A, Medina
G, Carter
C, Leis
J. 2004. Role of Nedd4 and ubiquitination of Rous sarcoma virus Gag in budding of virus-like particles from cells. J Virol
78:13943–13953. 10.1128/JVI.78.24.13943-13953.2004.15564502)
Vana
ML, Tang
Y, Chen
A, Medina
G, Carter
C, Leis
J. 2004. Role of Nedd4 and ubiquitination of Rous sarcoma virus Gag in budding of virus-like particles from cells. J Virol
78:13943–13953. 10.1128/JVI.78.24.13943-13953.2004.15564502
Vana
ML, Tang
Y, Chen
A, Medina
G, Carter
C, Leis
J. 2004. Role of Nedd4 and ubiquitination of Rous sarcoma virus Gag in budding of virus-like particles from cells. J Virol
78:13943–13953. 10.1128/JVI.78.24.13943-13953.2004.15564502, Vana
ML, Tang
Y, Chen
A, Medina
G, Carter
C, Leis
J. 2004. Role of Nedd4 and ubiquitination of Rous sarcoma virus Gag in budding of virus-like particles from cells. J Virol
78:13943–13953. 10.1128/JVI.78.24.13943-13953.2004.15564502
-
(Gottlinger
HG, Dorfman
T, Sodroski
JG, Haseltine
WA. 1991. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci U S A
88:3195–3199. 10.1073/pnas.88.8.3195.2014240)
Gottlinger
HG, Dorfman
T, Sodroski
JG, Haseltine
WA. 1991. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci U S A
88:3195–3199. 10.1073/pnas.88.8.3195.2014240
Gottlinger
HG, Dorfman
T, Sodroski
JG, Haseltine
WA. 1991. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci U S A
88:3195–3199. 10.1073/pnas.88.8.3195.2014240, Gottlinger
HG, Dorfman
T, Sodroski
JG, Haseltine
WA. 1991. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci U S A
88:3195–3199. 10.1073/pnas.88.8.3195.2014240
-
(Arii
J, Watanabe
M, Maeda
F, Tokai-Nishizumi
N, Chihara
T, Miura
M, Maruzuru
Y, Koyanagi
N, Kato
A, Kawaguchi
Y. 2018. ESCRT-III mediates budding across the inner nuclear membrane and regulates its integrity. Nat Commun
9:3379. 10.1038/s41467-018-05889-9.30139939)
Arii
J, Watanabe
M, Maeda
F, Tokai-Nishizumi
N, Chihara
T, Miura
M, Maruzuru
Y, Koyanagi
N, Kato
A, Kawaguchi
Y. 2018. ESCRT-III mediates budding across the inner nuclear membrane and regulates its integrity. Nat Commun
9:3379. 10.1038/s41467-018-05889-9.30139939
Arii
J, Watanabe
M, Maeda
F, Tokai-Nishizumi
N, Chihara
T, Miura
M, Maruzuru
Y, Koyanagi
N, Kato
A, Kawaguchi
Y. 2018. ESCRT-III mediates budding across the inner nuclear membrane and regulates its integrity. Nat Commun
9:3379. 10.1038/s41467-018-05889-9.30139939, Arii
J, Watanabe
M, Maeda
F, Tokai-Nishizumi
N, Chihara
T, Miura
M, Maruzuru
Y, Koyanagi
N, Kato
A, Kawaguchi
Y. 2018. ESCRT-III mediates budding across the inner nuclear membrane and regulates its integrity. Nat Commun
9:3379. 10.1038/s41467-018-05889-9.30139939
-
Weiming
Yuan,
J.
Aramini,
G.
Montelione,
R.
Krug
(2002)
Structural basis for ubiquitin-like ISG 15 protein binding to the NS1 protein of influenza B virus: a protein-protein interaction function that is not shared by the corresponding N-terminal domain of the NS1 protein of influenza A virus.
Virology, 304 2
-
A.
Calistri,
Denis
Munegato,
M.
Toffoletto,
Michele
Celestino,
E.
Franchin,
A.
Comin,
E.
Sartori,
C.
Salata,
C.
Parolin,
Giorgio
Palù
(2015)
Functional Interaction Between the ESCRT‐I Component TSG101 and the HSV‐1 Tegument Ubiquitin Specific Protease
Journal of Cellular Physiology, 230
-
Y.
Xiang,
C.
Cameron,
J.
Wills,
J.
Leis
(1996)
Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain
Journal of Virology, 70
-
(Almario
CV, Chey
WD, Spiegel
BMR. 2020. Increased risk of COVID-19 among users of proton pump inhibitors. Am J Gastroenterol
115:1707–1715. 10.14309/ajg.0000000000000798.32852340)
Almario
CV, Chey
WD, Spiegel
BMR. 2020. Increased risk of COVID-19 among users of proton pump inhibitors. Am J Gastroenterol
115:1707–1715. 10.14309/ajg.0000000000000798.32852340
Almario
CV, Chey
WD, Spiegel
BMR. 2020. Increased risk of COVID-19 among users of proton pump inhibitors. Am J Gastroenterol
115:1707–1715. 10.14309/ajg.0000000000000798.32852340, Almario
CV, Chey
WD, Spiegel
BMR. 2020. Increased risk of COVID-19 among users of proton pump inhibitors. Am J Gastroenterol
115:1707–1715. 10.14309/ajg.0000000000000798.32852340
-
A.
Goff,
L.
Ehrlich,
S.
Cohen,
C.
Carter
(2003)
Tsg101 Control of Human Immunodeficiency Virus Type 1 Gag Trafficking and Release
Journal of Virology, 77
-
(Chung
HY, Morita
E, von Schwedler
U, Muller
B, Krausslich
HG, Sundquist
WI. 2008. NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. J Virol
82:4884–4897. 10.1128/JVI.02667-07.18321968)
Chung
HY, Morita
E, von Schwedler
U, Muller
B, Krausslich
HG, Sundquist
WI. 2008. NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. J Virol
82:4884–4897. 10.1128/JVI.02667-07.18321968
Chung
HY, Morita
E, von Schwedler
U, Muller
B, Krausslich
HG, Sundquist
WI. 2008. NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. J Virol
82:4884–4897. 10.1128/JVI.02667-07.18321968, Chung
HY, Morita
E, von Schwedler
U, Muller
B, Krausslich
HG, Sundquist
WI. 2008. NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. J Virol
82:4884–4897. 10.1128/JVI.02667-07.18321968
-
Christopher
Almario,
W.
Chey,
B.
Spiegel
(2020)
Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors
The American Journal of Gastroenterology
-
(Lee
SK, Longnecker
R. 1997. The Epstein-Barr virus glycoprotein 110 carboxy-terminal tail domain is essential for lytic virus replication. J Virol
71:4092–4097. 10.1128/JVI.71.5.4092-4097.1997.9094688)
Lee
SK, Longnecker
R. 1997. The Epstein-Barr virus glycoprotein 110 carboxy-terminal tail domain is essential for lytic virus replication. J Virol
71:4092–4097. 10.1128/JVI.71.5.4092-4097.1997.9094688
Lee
SK, Longnecker
R. 1997. The Epstein-Barr virus glycoprotein 110 carboxy-terminal tail domain is essential for lytic virus replication. J Virol
71:4092–4097. 10.1128/JVI.71.5.4092-4097.1997.9094688, Lee
SK, Longnecker
R. 1997. The Epstein-Barr virus glycoprotein 110 carboxy-terminal tail domain is essential for lytic virus replication. J Virol
71:4092–4097. 10.1128/JVI.71.5.4092-4097.1997.9094688
-
S.
Watanabe,
L.
Ehrlich,
M.
Strickland,
Xiaofan
Li,
V.
Soloveva,
A.
Goff,
Charles
Stauft,
Sumita
Bhaduri-McIntosh,
N.
Tjandra,
C.
Carter
(2020)
Selective Targeting of Virus Replication by Proton Pump Inhibitors
Scientific Reports, 10
-
C.
Gordon,
E.
Tchesnokov,
Joy
Feng,
D.
Porter,
M.
Götte
(2020)
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
The Journal of Biological Chemistry, 295
-
(Irie
T, Harty
RN. 2005. L-domain flanking sequences are important for host interactions and efficient budding of vesicular stomatitis virus recombinants. J Virol
79:12617–12622. 10.1128/JVI.79.20.12617-12622.2005.16188963)
Irie
T, Harty
RN. 2005. L-domain flanking sequences are important for host interactions and efficient budding of vesicular stomatitis virus recombinants. J Virol
79:12617–12622. 10.1128/JVI.79.20.12617-12622.2005.16188963
Irie
T, Harty
RN. 2005. L-domain flanking sequences are important for host interactions and efficient budding of vesicular stomatitis virus recombinants. J Virol
79:12617–12622. 10.1128/JVI.79.20.12617-12622.2005.16188963, Irie
T, Harty
RN. 2005. L-domain flanking sequences are important for host interactions and efficient budding of vesicular stomatitis virus recombinants. J Virol
79:12617–12622. 10.1128/JVI.79.20.12617-12622.2005.16188963
-
Suk
Lee,
R.
Longnecker
(1997)
The Epstein-Barr virus glycoprotein 110 carboxy-terminal tail domain is essential for lytic virus replication
Journal of Virology, 71
-
E.
Seo,
J.
Leis
(2012)
Budding of Enveloped Viruses: Interferon-Induced ISG15—Antivirus Mechanisms Targeting the Release Process
Advances in Virology, 2012
-
N.
Bortoli,
I.
Martinucci,
Maria
Giacchino,
C.
Blandizzi,
S.
Marchi,
V.
Savarino,
E.
Savarino
(2013)
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment
Expert Opinion on Drug Metabolism & Toxicology, 9
-
Shuzo
Urata,
T.
Noda,
Y.
Kawaoka,
H.
Yokosawa,
J.
Yasuda
(2006)
Cellular Factors Required for Lassa Virus Budding
Journal of Virology, 80
-
Marcy
Vana,
Yi
Tang,
Aiping
Chen,
G.
Medina,
C.
Carter,
J.
Leis
(2004)
Role of Nedd4 and Ubiquitination of Rous Sarcoma Virus Gag in Budding of Virus-Like Particles from Cells
Journal of Virology, 78
-
L.
Silvestri,
G.
Ruthel,
G.
Kallstrom,
Kelly
Warfield,
D.
Swenson,
T.
Nelle,
P.
Iversen,
S.
Bavari,
M.
Aman,
Amanabadi
Javad
(2007)
Involvement of vacuolar protein sorting pathway in Ebola virus release independent of TSG101 interaction.
The Journal of infectious diseases, 196 Suppl 2
-
M.
Pantoliano,
E.
Petrella,
Joseph
Kwasnoski,
V.
Lobanov,
J.
Myslik,
Edward
Graf,
T.
Carver,
E.
Asel,
B.
Springer,
Pamela
Lane,
F.
Salemme
(2001)
High-Density Miniaturized Thermal Shift Assays as a General Strategy for Drug Discovery
Journal of Biomolecular Screening, 6
-
Y.
Ariumi,
Misao
Kuroki,
M.
Maki,
M.
Ikeda,
H.
Dansako,
T.
Wakita,
N.
Kato
(2011)
The ESCRT System Is Required for Hepatitis C Virus Production
PLoS ONE, 6
-
Chung-Pei
Lee,
Po-Ting
Liu,
H.
Kung,
Mei-Tzu
Su,
Huey‐Huey
Chua,
Yu‐Hsin
Chang,
Chou-Wei
Chang,
Ching-Hwa
Tsai,
Fu-Tong
Liu,
Mei-Ru
Chen
(2012)
The ESCRT Machinery Is Recruited by the Viral BFRF1 Protein to the Nucleus-Associated Membrane for the Maturation of Epstein-Barr Virus
PLoS Pathogens, 8
-
(Bojkova
D, McGreig
JE, McLaughlin
K-M, Masterson
SG, Widera
M, Kraehling
V, Ciesek
S, Wass
MN, Michaelis
M, Cinatl
JN. 2020. SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles. bioRxiv
10.1101/2020.04.03.024257.)
Bojkova
D, McGreig
JE, McLaughlin
K-M, Masterson
SG, Widera
M, Kraehling
V, Ciesek
S, Wass
MN, Michaelis
M, Cinatl
JN. 2020. SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles. bioRxiv
10.1101/2020.04.03.024257.
Bojkova
D, McGreig
JE, McLaughlin
K-M, Masterson
SG, Widera
M, Kraehling
V, Ciesek
S, Wass
MN, Michaelis
M, Cinatl
JN. 2020. SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles. bioRxiv
10.1101/2020.04.03.024257., Bojkova
D, McGreig
JE, McLaughlin
K-M, Masterson
SG, Widera
M, Kraehling
V, Ciesek
S, Wass
MN, Michaelis
M, Cinatl
JN. 2020. SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles. bioRxiv
10.1101/2020.04.03.024257.
-
(Seo
EJ, Leis
J. 2012. Budding of enveloped viruses: interferon-induced ISG15—antivirus mechanisms targeting the release process. Adv Virol
2012:532723. 10.1155/2012/532723.22666250)
Seo
EJ, Leis
J. 2012. Budding of enveloped viruses: interferon-induced ISG15—antivirus mechanisms targeting the release process. Adv Virol
2012:532723. 10.1155/2012/532723.22666250
Seo
EJ, Leis
J. 2012. Budding of enveloped viruses: interferon-induced ISG15—antivirus mechanisms targeting the release process. Adv Virol
2012:532723. 10.1155/2012/532723.22666250, Seo
EJ, Leis
J. 2012. Budding of enveloped viruses: interferon-induced ISG15—antivirus mechanisms targeting the release process. Adv Virol
2012:532723. 10.1155/2012/532723.22666250
-
(Bashirova
AA, Bleiber
G, Qi
Y, Hutcheson
H, Yamashita
T, Johnson
RC, Cheng
J, Alter
G, Goedert
JJ, Buchbinder
S, Hoots
K, Vlahov
D, May
M, Maldarelli
F, Jacobson
L, O’Brien
SJ, Telenti
A, Carrington
M. 2006. Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1. J Virol
80:6757–6763. 10.1128/jvi.00094-06.16809281)
Bashirova
AA, Bleiber
G, Qi
Y, Hutcheson
H, Yamashita
T, Johnson
RC, Cheng
J, Alter
G, Goedert
JJ, Buchbinder
S, Hoots
K, Vlahov
D, May
M, Maldarelli
F, Jacobson
L, O’Brien
SJ, Telenti
A, Carrington
M. 2006. Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1. J Virol
80:6757–6763. 10.1128/jvi.00094-06.16809281
Bashirova
AA, Bleiber
G, Qi
Y, Hutcheson
H, Yamashita
T, Johnson
RC, Cheng
J, Alter
G, Goedert
JJ, Buchbinder
S, Hoots
K, Vlahov
D, May
M, Maldarelli
F, Jacobson
L, O’Brien
SJ, Telenti
A, Carrington
M. 2006. Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1. J Virol
80:6757–6763. 10.1128/jvi.00094-06.16809281, Bashirova
AA, Bleiber
G, Qi
Y, Hutcheson
H, Yamashita
T, Johnson
RC, Cheng
J, Alter
G, Goedert
JJ, Buchbinder
S, Hoots
K, Vlahov
D, May
M, Maldarelli
F, Jacobson
L, O’Brien
SJ, Telenti
A, Carrington
M. 2006. Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1. J Virol
80:6757–6763. 10.1128/jvi.00094-06.16809281
-
(Pantoliano
MW, Petrella
EC, Kwasnoski
JD, Lobanov
VS, Myslik
J, Graf
E, Carver
T, Asel
E, Springer
BA, Lane
P, Salemme
FR. 2001. High-density miniaturized thermal shift assays as a general strategy for drug discovery. J Biomol Screen
6:429–440. 10.1177/108705710100600609.11788061)
Pantoliano
MW, Petrella
EC, Kwasnoski
JD, Lobanov
VS, Myslik
J, Graf
E, Carver
T, Asel
E, Springer
BA, Lane
P, Salemme
FR. 2001. High-density miniaturized thermal shift assays as a general strategy for drug discovery. J Biomol Screen
6:429–440. 10.1177/108705710100600609.11788061
Pantoliano
MW, Petrella
EC, Kwasnoski
JD, Lobanov
VS, Myslik
J, Graf
E, Carver
T, Asel
E, Springer
BA, Lane
P, Salemme
FR. 2001. High-density miniaturized thermal shift assays as a general strategy for drug discovery. J Biomol Screen
6:429–440. 10.1177/108705710100600609.11788061, Pantoliano
MW, Petrella
EC, Kwasnoski
JD, Lobanov
VS, Myslik
J, Graf
E, Carver
T, Asel
E, Springer
BA, Lane
P, Salemme
FR. 2001. High-density miniaturized thermal shift assays as a general strategy for drug discovery. J Biomol Screen
6:429–440. 10.1177/108705710100600609.11788061
-
M.
Strickland,
L.
Ehrlich,
S.
Watanabe,
Mahfuz
Khan,
M.
Strub,
C.
Luan,
M.
Powell,
J.
Leis,
N.
Tjandra,
C.
Carter
(2017)
Tsg101 chaperone function revealed by HIV-1 assembly inhibitors
Nature Communications, 8
-
M.
Arguello,
J.
Hiscott
(2007)
Ub surprised: viral ovarian tumor domain proteases remove ubiquitin and ISG15 conjugates.
Cell host & microbe, 2 6
-
A.
Schmitt,
G.
Leser,
E.
Morita,
W.
Sundquist,
R.
Lamb
(2005)
Evidence for a New Viral Late-Domain Core Sequence, FPIV, Necessary for Budding of a Paramyxovirus
Journal of Virology, 79
-
(Harty
RN, Pitha
PM, Okumura
A. 2009. Antiviral activity of innate immune protein ISG15. J Innate Immun
1:397–404. 10.1159/000226245.19680460)
Harty
RN, Pitha
PM, Okumura
A. 2009. Antiviral activity of innate immune protein ISG15. J Innate Immun
1:397–404. 10.1159/000226245.19680460
Harty
RN, Pitha
PM, Okumura
A. 2009. Antiviral activity of innate immune protein ISG15. J Innate Immun
1:397–404. 10.1159/000226245.19680460, Harty
RN, Pitha
PM, Okumura
A. 2009. Antiviral activity of innate immune protein ISG15. J Innate Immun
1:397–404. 10.1159/000226245.19680460
-
G.
Taylor,
P.
Hanson,
M.
Kielian
(2007)
Ubiquitin Depletion and Dominant-Negative VPS4 Inhibit Rhabdovirus Budding without Affecting Alphavirus Budding
Journal of Virology, 81
-
Joanna
Timmins,
G.
Schoehn,
S.
Ricard-Blum,
S.
Scianimanico,
T.
Vernet,
R.
Ruigrok,
W.
Weissenhorn
(2003)
Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4.
Journal of molecular biology, 326 2
-
J.
Martin-Serrano,
Trinity
Zang,
P.
Bieniasz
(2001)
HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress
Nature Medicine, 7
-
(Lambert
C, Döring
T, Prange
R. 2007. Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and γ2-adaptin. J Virol
81:9050–9060. 10.1128/JVI.00479-07.17553870)
Lambert
C, Döring
T, Prange
R. 2007. Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and γ2-adaptin. J Virol
81:9050–9060. 10.1128/JVI.00479-07.17553870
Lambert
C, Döring
T, Prange
R. 2007. Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and γ2-adaptin. J Virol
81:9050–9060. 10.1128/JVI.00479-07.17553870, Lambert
C, Döring
T, Prange
R. 2007. Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and γ2-adaptin. J Virol
81:9050–9060. 10.1128/JVI.00479-07.17553870
-
(Li
M, Schmitt
PT, Li
Z, McCrory
TS, He
B, Schmitt
AP. 2009. Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol
83:7261–7272. 10.1128/JVI.00421-09.19439476)
Li
M, Schmitt
PT, Li
Z, McCrory
TS, He
B, Schmitt
AP. 2009. Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol
83:7261–7272. 10.1128/JVI.00421-09.19439476
Li
M, Schmitt
PT, Li
Z, McCrory
TS, He
B, Schmitt
AP. 2009. Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol
83:7261–7272. 10.1128/JVI.00421-09.19439476, Li
M, Schmitt
PT, Li
Z, McCrory
TS, He
B, Schmitt
AP. 2009. Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol
83:7261–7272. 10.1128/JVI.00421-09.19439476
-
O.
Pornillos,
S.
Alam,
R.
Rich,
D.
Myszka,
D.
Davis,
W.
Sundquist
(2002)
Structure and functional interactions of the Tsg101 UEV domain
The EMBO Journal, 21
-
(2007)
Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and g2-adaptin
-
(Strickland
M, Ehrlich
LS, Watanabe
S, Khan
M, Strub
MP, Luan
CH, Powell
MD, Leis
J, Tjandra
N, Carter
CA. 2017. Tsg101 chaperone function revealed by HIV-1 assembly inhibitors. Nat Commun
8:1391. 10.1038/s41467-017-01426-2.29123089)
Strickland
M, Ehrlich
LS, Watanabe
S, Khan
M, Strub
MP, Luan
CH, Powell
MD, Leis
J, Tjandra
N, Carter
CA. 2017. Tsg101 chaperone function revealed by HIV-1 assembly inhibitors. Nat Commun
8:1391. 10.1038/s41467-017-01426-2.29123089
Strickland
M, Ehrlich
LS, Watanabe
S, Khan
M, Strub
MP, Luan
CH, Powell
MD, Leis
J, Tjandra
N, Carter
CA. 2017. Tsg101 chaperone function revealed by HIV-1 assembly inhibitors. Nat Commun
8:1391. 10.1038/s41467-017-01426-2.29123089, Strickland
M, Ehrlich
LS, Watanabe
S, Khan
M, Strub
MP, Luan
CH, Powell
MD, Leis
J, Tjandra
N, Carter
CA. 2017. Tsg101 chaperone function revealed by HIV-1 assembly inhibitors. Nat Commun
8:1391. 10.1038/s41467-017-01426-2.29123089
-
J.
Shin,
Nayoung
Kim
(2013)
Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
Journal of Neurogastroenterology and Motility, 19
-
R.
Harty,
P.
Pitha,
A.
Okumura
(2009)
Antiviral Activity of Innate Immune Protein ISG15
Journal of Innate Immunity, 1
-
Jez
Carlton,
J.
Martin-Serrano
(2007)
Parallels Between Cytokinesis and Retroviral Budding: A Role for the ESCRT Machinery
Science, 316
-
(de Bortoli
N, Martinucci
I, Giacchino
M, Blandizzi
C, Marchi
S, Savarino
V, Savarino
E. 2013. The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment. Expert Opin Drug Metab Toxicol
9:1361–1369. 10.1517/17425255.2013.813018.23802731)
de Bortoli
N, Martinucci
I, Giacchino
M, Blandizzi
C, Marchi
S, Savarino
V, Savarino
E. 2013. The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment. Expert Opin Drug Metab Toxicol
9:1361–1369. 10.1517/17425255.2013.813018.23802731
de Bortoli
N, Martinucci
I, Giacchino
M, Blandizzi
C, Marchi
S, Savarino
V, Savarino
E. 2013. The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment. Expert Opin Drug Metab Toxicol
9:1361–1369. 10.1517/17425255.2013.813018.23802731, de Bortoli
N, Martinucci
I, Giacchino
M, Blandizzi
C, Marchi
S, Savarino
V, Savarino
E. 2013. The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment. Expert Opin Drug Metab Toxicol
9:1361–1369. 10.1517/17425255.2013.813018.23802731
-
(Ariumi
Y, Kuroki
M, Maki
M, Ikeda
M, Dansako
H, Wakita
T, Kato
N. 2011. The ESCRT system is required for hepatitis C virus production. PLoS One
6:e14517. 10.1371/journal.pone.0014517.21264300)
Ariumi
Y, Kuroki
M, Maki
M, Ikeda
M, Dansako
H, Wakita
T, Kato
N. 2011. The ESCRT system is required for hepatitis C virus production. PLoS One
6:e14517. 10.1371/journal.pone.0014517.21264300
Ariumi
Y, Kuroki
M, Maki
M, Ikeda
M, Dansako
H, Wakita
T, Kato
N. 2011. The ESCRT system is required for hepatitis C virus production. PLoS One
6:e14517. 10.1371/journal.pone.0014517.21264300, Ariumi
Y, Kuroki
M, Maki
M, Ikeda
M, Dansako
H, Wakita
T, Kato
N. 2011. The ESCRT system is required for hepatitis C virus production. PLoS One
6:e14517. 10.1371/journal.pone.0014517.21264300
-
Md.
Al-Bari
(2017)
Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases
Pharmacology Research & Perspectives, 5
-
A.
Calistri,
P.
Sette,
C.
Salata,
E.
Cancellotti,
Cristina
Forghieri,
A.
Comin,
H.
Göttlinger,
G.
Campadelli-Fiume,
G.
Palù,
C.
Parolin
(2007)
Intracellular Trafficking and Maturation of Herpes Simplex Virus Type 1 gB and Virus Egress Require Functional Biogenesis of Multivesicular Bodies
Journal of Virology, 81
-
(Al-Bari
MAA. 2017. Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases. Pharmacol Res Perspect
5:e00293. 10.1002/prp2.293.28596841)
Al-Bari
MAA. 2017. Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases. Pharmacol Res Perspect
5:e00293. 10.1002/prp2.293.28596841
Al-Bari
MAA. 2017. Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases. Pharmacol Res Perspect
5:e00293. 10.1002/prp2.293.28596841, Al-Bari
MAA. 2017. Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases. Pharmacol Res Perspect
5:e00293. 10.1002/prp2.293.28596841
-
(Xiang
Y, Cameron
CE, Wills
JW, Leis
J. 1996. Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J Virol
70:5695–5700. 10.1128/JVI.70.8.5695-5700.1996.8764091)
Xiang
Y, Cameron
CE, Wills
JW, Leis
J. 1996. Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J Virol
70:5695–5700. 10.1128/JVI.70.8.5695-5700.1996.8764091
Xiang
Y, Cameron
CE, Wills
JW, Leis
J. 1996. Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J Virol
70:5695–5700. 10.1128/JVI.70.8.5695-5700.1996.8764091, Xiang
Y, Cameron
CE, Wills
JW, Leis
J. 1996. Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J Virol
70:5695–5700. 10.1128/JVI.70.8.5695-5700.1996.8764091
-
(Taylor
GM, Hanson
PI, Kielian
M. 2007. Ubiquitin depletion and dominant-negative VPS4 inhibit rhabdovirus budding without affecting alphavirus budding. J Virol
81:13631–13639. 10.1128/JVI.01688-07.17913808)
Taylor
GM, Hanson
PI, Kielian
M. 2007. Ubiquitin depletion and dominant-negative VPS4 inhibit rhabdovirus budding without affecting alphavirus budding. J Virol
81:13631–13639. 10.1128/JVI.01688-07.17913808
Taylor
GM, Hanson
PI, Kielian
M. 2007. Ubiquitin depletion and dominant-negative VPS4 inhibit rhabdovirus budding without affecting alphavirus budding. J Virol
81:13631–13639. 10.1128/JVI.01688-07.17913808, Taylor
GM, Hanson
PI, Kielian
M. 2007. Ubiquitin depletion and dominant-negative VPS4 inhibit rhabdovirus budding without affecting alphavirus budding. J Virol
81:13631–13639. 10.1128/JVI.01688-07.17913808
-
J.
Martin-Serrano,
A.
Yaravoy,
D.
Pérez-Caballero,
P.
Bieniasz
(2003)
Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins
Proceedings of the National Academy of Sciences of the United States of America, 100
-
(Medina
G, Zhang
Y, Tang
Y, Gottwein
E, Vana
ML, Bouamr
F, Leis
J, Carter
CA. 2005. The functionally exchangeable L domains in RSV and HIV‐1 Gag direct particle release through pathways linked by Tsg101. Traffic
6:880–894. 10.1111/j.1600-0854.2005.00323.x.16138902)
Medina
G, Zhang
Y, Tang
Y, Gottwein
E, Vana
ML, Bouamr
F, Leis
J, Carter
CA. 2005. The functionally exchangeable L domains in RSV and HIV‐1 Gag direct particle release through pathways linked by Tsg101. Traffic
6:880–894. 10.1111/j.1600-0854.2005.00323.x.16138902
Medina
G, Zhang
Y, Tang
Y, Gottwein
E, Vana
ML, Bouamr
F, Leis
J, Carter
CA. 2005. The functionally exchangeable L domains in RSV and HIV‐1 Gag direct particle release through pathways linked by Tsg101. Traffic
6:880–894. 10.1111/j.1600-0854.2005.00323.x.16138902, Medina
G, Zhang
Y, Tang
Y, Gottwein
E, Vana
ML, Bouamr
F, Leis
J, Carter
CA. 2005. The functionally exchangeable L domains in RSV and HIV‐1 Gag direct particle release through pathways linked by Tsg101. Traffic
6:880–894. 10.1111/j.1600-0854.2005.00323.x.16138902
-
(Tandon
R, AuCoin
DP, Mocarski
ES. 2009. Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation. J Virol
83:10797–10807. 10.1128/JVI.01093-09.19640981)
Tandon
R, AuCoin
DP, Mocarski
ES. 2009. Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation. J Virol
83:10797–10807. 10.1128/JVI.01093-09.19640981
Tandon
R, AuCoin
DP, Mocarski
ES. 2009. Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation. J Virol
83:10797–10807. 10.1128/JVI.01093-09.19640981, Tandon
R, AuCoin
DP, Mocarski
ES. 2009. Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation. J Virol
83:10797–10807. 10.1128/JVI.01093-09.19640981
-
A.
Bashirova,
Gabriela
Bleiber,
Y.
Qi,
H.
Hutcheson,
T.
Yamashita,
Randall
Johnson,
Jie
Cheng,
G.
Alter,
J.
Goedert,
S.
Buchbinder,
K.
Hoots,
D.
Vlahov,
M.
May,
F.
Maldarelli,
L.
Jacobson,
S.
O’Brien,
A.
Telenti,
M.
Carrington
(2018)
Consistent Effects of TSG 101 Genetic Variability on Multiple Outcomes of Exposure to Human Immunodeficiency Virus Type 1 †
-
(Pincetic
A, Kuang
Z, Seo
EJ, Leis
J. 2010. The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J Virol
84:4725–4736. 10.1128/JVI.02478-09.20164219)
Pincetic
A, Kuang
Z, Seo
EJ, Leis
J. 2010. The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J Virol
84:4725–4736. 10.1128/JVI.02478-09.20164219
Pincetic
A, Kuang
Z, Seo
EJ, Leis
J. 2010. The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J Virol
84:4725–4736. 10.1128/JVI.02478-09.20164219, Pincetic
A, Kuang
Z, Seo
EJ, Leis
J. 2010. The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J Virol
84:4725–4736. 10.1128/JVI.02478-09.20164219
-
R.
Tandon,
D.
Aucoin,
E.
Mocarski
(2009)
Human Cytomegalovirus Exploits ESCRT Machinery in the Process of Virion Maturation
Journal of Virology, 83
-
A.
Bashirova,
Gabriela
Bleiber,
Y.
Qi,
H.
Hutcheson,
T.
Yamashita,
Randall
Johnson,
Jie
Cheng,
G.
Alter,
J.
Goedert,
S.
Buchbinder,
K.
Hoots,
D.
Vlahov,
M.
May,
F.
Maldarelli,
L.
Jacobson,
S.
O’Brien,
A.
Telenti,
M.
Carrington
(2006)
Consistent Effects of TSG101 Genetic Variability on Multiple Outcomes of Exposure to Human Immunodeficiency Virus Type 1
Journal of Virology, 80
-
(Arguello
MD, Hiscott
J. 2007. Ub surprised: viral ovarian tumor domain proteases remove ubiquitin and ISG15 conjugates. Cell Host Microbe
2:367–369. 10.1016/j.chom.2007.11.005.18078688)
Arguello
MD, Hiscott
J. 2007. Ub surprised: viral ovarian tumor domain proteases remove ubiquitin and ISG15 conjugates. Cell Host Microbe
2:367–369. 10.1016/j.chom.2007.11.005.18078688
Arguello
MD, Hiscott
J. 2007. Ub surprised: viral ovarian tumor domain proteases remove ubiquitin and ISG15 conjugates. Cell Host Microbe
2:367–369. 10.1016/j.chom.2007.11.005.18078688, Arguello
MD, Hiscott
J. 2007. Ub surprised: viral ovarian tumor domain proteases remove ubiquitin and ISG15 conjugates. Cell Host Microbe
2:367–369. 10.1016/j.chom.2007.11.005.18078688
-
(Calistri
A, Munegato
D, Toffoletto
M, Celestino
M, Franchin
E, Comin
A, Sartori
E, Salata
C, Parolin
C, Palu
G. 2015. Functional interaction between the ESCRT‐I component TSG101 and the HSV‐1 tegument ubiquitin specific protease. J Cell Physiol
230:1794–1806. 10.1002/jcp.24890.25510868)
Calistri
A, Munegato
D, Toffoletto
M, Celestino
M, Franchin
E, Comin
A, Sartori
E, Salata
C, Parolin
C, Palu
G. 2015. Functional interaction between the ESCRT‐I component TSG101 and the HSV‐1 tegument ubiquitin specific protease. J Cell Physiol
230:1794–1806. 10.1002/jcp.24890.25510868
Calistri
A, Munegato
D, Toffoletto
M, Celestino
M, Franchin
E, Comin
A, Sartori
E, Salata
C, Parolin
C, Palu
G. 2015. Functional interaction between the ESCRT‐I component TSG101 and the HSV‐1 tegument ubiquitin specific protease. J Cell Physiol
230:1794–1806. 10.1002/jcp.24890.25510868, Calistri
A, Munegato
D, Toffoletto
M, Celestino
M, Franchin
E, Comin
A, Sartori
E, Salata
C, Parolin
C, Palu
G. 2015. Functional interaction between the ESCRT‐I component TSG101 and the HSV‐1 tegument ubiquitin specific protease. J Cell Physiol
230:1794–1806. 10.1002/jcp.24890.25510868
-
G.
Medina,
Yongjun
Zhang,
Yi
Tang,
E.
Gottwein,
Marcy
Vana,
F.
Bouamr,
J.
Leis,
C.
Carter
(2005)
The Functionally Exchangeable L Domains in RSV and HIV‐1 Gag Direct Particle Release Through Pathways Linked by Tsg101
Traffic, 6
-
J.
Shin,
G.
Sachs
(2002)
Restoration of acid secretion following treatment with proton pump inhibitors.
Gastroenterology, 123 5
-
(Strack
B, Calistri
A, Craig
S, Popova
E, Göttlinger
HG. 2003. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell
114:689–699. 10.1016/s0092-8674(03)00653-6.14505569)
Strack
B, Calistri
A, Craig
S, Popova
E, Göttlinger
HG. 2003. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell
114:689–699. 10.1016/s0092-8674(03)00653-6.14505569
Strack
B, Calistri
A, Craig
S, Popova
E, Göttlinger
HG. 2003. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell
114:689–699. 10.1016/s0092-8674(03)00653-6.14505569, Strack
B, Calistri
A, Craig
S, Popova
E, Göttlinger
HG. 2003. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell
114:689–699. 10.1016/s0092-8674(03)00653-6.14505569
-
(Yuan
W, Krug
RM. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J
20:362–371. 10.1093/emboj/20.3.362.11157743)
Yuan
W, Krug
RM. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J
20:362–371. 10.1093/emboj/20.3.362.11157743
Yuan
W, Krug
RM. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J
20:362–371. 10.1093/emboj/20.3.362.11157743, Yuan
W, Krug
RM. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J
20:362–371. 10.1093/emboj/20.3.362.11157743
-
B.
Kakinoki,
C.
Ono,
N.
Yamazaki,
N.
Chikamatsu,
D.
Wakatsuki,
K.
Uchiyama,
Y.
Morinaka
(1999)
General pharmacological properties of the new proton pump inhibitor (+/-)-5-methoxy-2-[[(4-methoxy-3,5-dimethylpyrid-2-yl)methyl]sulf inyl]- 1H-imidazo[4,5-b]pyridine.
Methods and findings in experimental and clinical pharmacology, 21 3
-
R.
Harty,
Melissa
Brown,
Guangli
Wang,
J.
Huibregtse,
Felicia
Hayes
(2000)
A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding.
Proceedings of the National Academy of Sciences of the United States of America, 97 25
-
(Gordon
CJ, Tchesnokov
EP, Feng
JY, Porter
DP, Gotte
M. 2020. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J Biol Chem
295:4773–4779. 10.1074/jbc.AC120.013056.32094225)
Gordon
CJ, Tchesnokov
EP, Feng
JY, Porter
DP, Gotte
M. 2020. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J Biol Chem
295:4773–4779. 10.1074/jbc.AC120.013056.32094225
Gordon
CJ, Tchesnokov
EP, Feng
JY, Porter
DP, Gotte
M. 2020. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J Biol Chem
295:4773–4779. 10.1074/jbc.AC120.013056.32094225, Gordon
CJ, Tchesnokov
EP, Feng
JY, Porter
DP, Gotte
M. 2020. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J Biol Chem
295:4773–4779. 10.1074/jbc.AC120.013056.32094225
-
C.
Crump,
C.
Yates,
T.
Minson
(2007)
Herpes Simplex Virus Type 1 Cytoplasmic Envelopment Requires Functional Vps4
Journal of Virology, 81
-
(Martin-Serrano
J, Zang
T, Bieniasz
PD. 2001. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med
7:1313–1319. 10.1038/nm1201-1313.11726971)
Martin-Serrano
J, Zang
T, Bieniasz
PD. 2001. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med
7:1313–1319. 10.1038/nm1201-1313.11726971
Martin-Serrano
J, Zang
T, Bieniasz
PD. 2001. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med
7:1313–1319. 10.1038/nm1201-1313.11726971, Martin-Serrano
J, Zang
T, Bieniasz
PD. 2001. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med
7:1313–1319. 10.1038/nm1201-1313.11726971
-
Zhizhou
Kuang,
E.
Seo,
J.
Leis
(2011)
Mechanism of Inhibition of Retrovirus Release from Cells by Interferon-Induced Gene ISG15
Journal of Virology, 85
-
Andrew
Pincetic,
Zhizhou
Kuang,
E.
Seo,
J.
Leis
(2010)
The Interferon-Induced Gene ISG15 Blocks Retrovirus Release from Cells Late in the Budding Process
Journal of Virology, 84
-
L.
Corless,
C.
Crump,
Stephen
Griffin,
M.
Harris
(2010)
Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles.
The Journal of general virology, 91 Pt 2
-
(Usami
Y, Popov
S, Popova
E, Gottlinger
HG. 2008. Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase. J Virol
82:4898–4907. 10.1128/JVI.02675-07.18321969)
Usami
Y, Popov
S, Popova
E, Gottlinger
HG. 2008. Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase. J Virol
82:4898–4907. 10.1128/JVI.02675-07.18321969
Usami
Y, Popov
S, Popova
E, Gottlinger
HG. 2008. Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase. J Virol
82:4898–4907. 10.1128/JVI.02675-07.18321969, Usami
Y, Popov
S, Popova
E, Gottlinger
HG. 2008. Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase. J Virol
82:4898–4907. 10.1128/JVI.02675-07.18321969
-
(Shin
JM, Sachs
G. 2002. Restoration of acid secretion following treatment with proton pump inhibitors. Gastroenterology
123:1588–1597. 10.1053/gast.2002.36593.12404233)
Shin
JM, Sachs
G. 2002. Restoration of acid secretion following treatment with proton pump inhibitors. Gastroenterology
123:1588–1597. 10.1053/gast.2002.36593.12404233
Shin
JM, Sachs
G. 2002. Restoration of acid secretion following treatment with proton pump inhibitors. Gastroenterology
123:1588–1597. 10.1053/gast.2002.36593.12404233, Shin
JM, Sachs
G. 2002. Restoration of acid secretion following treatment with proton pump inhibitors. Gastroenterology
123:1588–1597. 10.1053/gast.2002.36593.12404233
-
(von Schwedler
UK, Stuchell
M, Muller
B, Ward
DM, Chung
HY, Morita
E, Wang
HE, Davis
T, He
GP, Cimbora
DM, Scott
A, Krausslich
HG, Kaplan
J, Morham
SG, Sundquist
WI. 2003. The protein network of HIV budding. Cell
114:701–713. 10.1016/s0092-8674(03)00714-1.14505570)
von Schwedler
UK, Stuchell
M, Muller
B, Ward
DM, Chung
HY, Morita
E, Wang
HE, Davis
T, He
GP, Cimbora
DM, Scott
A, Krausslich
HG, Kaplan
J, Morham
SG, Sundquist
WI. 2003. The protein network of HIV budding. Cell
114:701–713. 10.1016/s0092-8674(03)00714-1.14505570
von Schwedler
UK, Stuchell
M, Muller
B, Ward
DM, Chung
HY, Morita
E, Wang
HE, Davis
T, He
GP, Cimbora
DM, Scott
A, Krausslich
HG, Kaplan
J, Morham
SG, Sundquist
WI. 2003. The protein network of HIV budding. Cell
114:701–713. 10.1016/s0092-8674(03)00714-1.14505570, von Schwedler
UK, Stuchell
M, Muller
B, Ward
DM, Chung
HY, Morita
E, Wang
HE, Davis
T, He
GP, Cimbora
DM, Scott
A, Krausslich
HG, Kaplan
J, Morham
SG, Sundquist
WI. 2003. The protein network of HIV budding. Cell
114:701–713. 10.1016/s0092-8674(03)00714-1.14505570
-
S.
Urata,
T.
Noda,
Y.
Kawaoka,
S.
Morikawa,
H.
Yokosawa,
J.
Yasuda
(2007)
Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP
J Virol, 81
-
(Crump
CM, Yates
C, Minson
T. 2007. Herpes simplex virus type 1 cytoplasmic envelopment requires functional Vps4. J Virol
81:7380–7387. 10.1128/JVI.00222-07.17507493)
Crump
CM, Yates
C, Minson
T. 2007. Herpes simplex virus type 1 cytoplasmic envelopment requires functional Vps4. J Virol
81:7380–7387. 10.1128/JVI.00222-07.17507493
Crump
CM, Yates
C, Minson
T. 2007. Herpes simplex virus type 1 cytoplasmic envelopment requires functional Vps4. J Virol
81:7380–7387. 10.1128/JVI.00222-07.17507493, Crump
CM, Yates
C, Minson
T. 2007. Herpes simplex virus type 1 cytoplasmic envelopment requires functional Vps4. J Virol
81:7380–7387. 10.1128/JVI.00222-07.17507493
-
(Madara
JJ, Han
Z, Ruthel
G, Freedman
BD, Harty
RN. 2015. The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target. Future Virol
10:537–546. 10.2217/fvl.15.6.26120351)
Madara
JJ, Han
Z, Ruthel
G, Freedman
BD, Harty
RN. 2015. The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target. Future Virol
10:537–546. 10.2217/fvl.15.6.26120351
Madara
JJ, Han
Z, Ruthel
G, Freedman
BD, Harty
RN. 2015. The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target. Future Virol
10:537–546. 10.2217/fvl.15.6.26120351, Madara
JJ, Han
Z, Ruthel
G, Freedman
BD, Harty
RN. 2015. The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target. Future Virol
10:537–546. 10.2217/fvl.15.6.26120351
-
C.
Wirblich,
G.
Tan,
Amy
Papaneri,
Peter
Godlewski,
J.
Orenstein,
R.
Harty,
M.
Schnell
(2008)
PPEY Motif within the Rabies Virus (RV) Matrix Protein Is Essential for Efficient Virion Release and RV Pathogenicity
Journal of Virology, 82
-
(Pornillos
O, Alam
SL, Rich
RL, Myszka
DG, Davis
DR, Sundquist
WI. 2002. Structure and functional interactions of the Tsg101 UEV domain. EMBO J
21:2397–2406. 10.1093/emboj/21.10.2397.12006492)
Pornillos
O, Alam
SL, Rich
RL, Myszka
DG, Davis
DR, Sundquist
WI. 2002. Structure and functional interactions of the Tsg101 UEV domain. EMBO J
21:2397–2406. 10.1093/emboj/21.10.2397.12006492
Pornillos
O, Alam
SL, Rich
RL, Myszka
DG, Davis
DR, Sundquist
WI. 2002. Structure and functional interactions of the Tsg101 UEV domain. EMBO J
21:2397–2406. 10.1093/emboj/21.10.2397.12006492, Pornillos
O, Alam
SL, Rich
RL, Myszka
DG, Davis
DR, Sundquist
WI. 2002. Structure and functional interactions of the Tsg101 UEV domain. EMBO J
21:2397–2406. 10.1093/emboj/21.10.2397.12006492
-
(Fujii
K, Munshi
UM, Ablan
SD, Demirov
DG, Soheilian
F, Nagashima
K, Stephen
AG, Fisher
RJ, Freed
EO. 2009. Functional role of Alix in HIV-1 replication. Virology
391:284–292. 10.1016/j.virol.2009.06.016.19596386)
Fujii
K, Munshi
UM, Ablan
SD, Demirov
DG, Soheilian
F, Nagashima
K, Stephen
AG, Fisher
RJ, Freed
EO. 2009. Functional role of Alix in HIV-1 replication. Virology
391:284–292. 10.1016/j.virol.2009.06.016.19596386
Fujii
K, Munshi
UM, Ablan
SD, Demirov
DG, Soheilian
F, Nagashima
K, Stephen
AG, Fisher
RJ, Freed
EO. 2009. Functional role of Alix in HIV-1 replication. Virology
391:284–292. 10.1016/j.virol.2009.06.016.19596386, Fujii
K, Munshi
UM, Ablan
SD, Demirov
DG, Soheilian
F, Nagashima
K, Stephen
AG, Fisher
RJ, Freed
EO. 2009. Functional role of Alix in HIV-1 replication. Virology
391:284–292. 10.1016/j.virol.2009.06.016.19596386
-
C.
Luan,
S.
Light,
S.
Dunne,
W.
Anderson
(2014)
Ligand screening using fluorescence thermal shift analysis (FTS).
Methods in molecular biology, 1140
-
(VerPlank
L, Bouamr
F, LaGrassa
TJ, Agresta
B, Kikonyogo
A, Leis
J, Carter
CA. 2001. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag. Proc Natl Acad Sci U S A
98:7724–7729. 10.1073/pnas.131059198.11427703)
VerPlank
L, Bouamr
F, LaGrassa
TJ, Agresta
B, Kikonyogo
A, Leis
J, Carter
CA. 2001. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag. Proc Natl Acad Sci U S A
98:7724–7729. 10.1073/pnas.131059198.11427703
VerPlank
L, Bouamr
F, LaGrassa
TJ, Agresta
B, Kikonyogo
A, Leis
J, Carter
CA. 2001. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag. Proc Natl Acad Sci U S A
98:7724–7729. 10.1073/pnas.131059198.11427703, VerPlank
L, Bouamr
F, LaGrassa
TJ, Agresta
B, Kikonyogo
A, Leis
J, Carter
CA. 2001. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag. Proc Natl Acad Sci U S A
98:7724–7729. 10.1073/pnas.131059198.11427703
-
(Wirblich
C, Tan
GS, Papaneri
A, Godlewski
PJ, Orenstein
JM, Harty
RN, Schnell
MJ. 2008. PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity. J Virol
82:9730–9738. 10.1128/JVI.00889-08.18667490)
Wirblich
C, Tan
GS, Papaneri
A, Godlewski
PJ, Orenstein
JM, Harty
RN, Schnell
MJ. 2008. PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity. J Virol
82:9730–9738. 10.1128/JVI.00889-08.18667490
Wirblich
C, Tan
GS, Papaneri
A, Godlewski
PJ, Orenstein
JM, Harty
RN, Schnell
MJ. 2008. PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity. J Virol
82:9730–9738. 10.1128/JVI.00889-08.18667490, Wirblich
C, Tan
GS, Papaneri
A, Godlewski
PJ, Orenstein
JM, Harty
RN, Schnell
MJ. 2008. PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity. J Virol
82:9730–9738. 10.1128/JVI.00889-08.18667490
-
Andrew
Pincetic,
G.
Medina,
C.
Carter,
J.
Leis
(2008)
Avian Sarcoma Virus and Human Immunodeficiency Virus, Type 1 Use Different Subsets of ESCRT Proteins to Facilitate the Budding Process*
Journal of Biological Chemistry, 283
-
(Perez
M, Craven
RC, de la Torre
JC. 2003. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A
100:12978–12983. 10.1073/pnas.2133782100.14563923)
Perez
M, Craven
RC, de la Torre
JC. 2003. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A
100:12978–12983. 10.1073/pnas.2133782100.14563923
Perez
M, Craven
RC, de la Torre
JC. 2003. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A
100:12978–12983. 10.1073/pnas.2133782100.14563923, Perez
M, Craven
RC, de la Torre
JC. 2003. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A
100:12978–12983. 10.1073/pnas.2133782100.14563923